CHANTILLY, Va.–(BUSINESS WIRE)–Notal Vision, Inc. is pleased to announce that the ForeseeHome AMD Monitoring Program is now available for eligible Medicare patients across the U.S. ForeseeHome is available by prescription for patients with Dry Age-related Macular Degeneration (AMD) at high risk for developing Wet AMD. The clinical utility for ForeseeHome was established in the Home Monitoring of the Eye (HOME) Study, part of a National Eye Institute-sponsored study, where over 1500 patients w
LEXINGTON, Mass.–(BUSINESS WIRE)–David P. Southwell, President and CEO of Inotek, will present at Cowen and Company’s 36th Annual Health Care Conference on Monday, March 7th, 2016 at 2:00 ET at the Boston Marriott Copley Place Hotel
SAN DIEGO–(BUSINESS WIRE)–ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system disorders, today announced its financial results for the fourth quarter and year ended December 31, 2015. “2015 was highlighted by the filing of our NUPLAZID™ (pimavanserin) New Drug Application for Parkinson’s disease psychosis and the designation of Priority Review b
A two-year clinical trial that compared three drugs for diabetic macular edema (DME) found that gains in vision were greater for participants receiving the drug Eylea (aflibercept) than for those…
Uncorrected refractive error (URE)–nearsightedness, farsightedness, and other focusing problems correctable by prescription lenses–is responsible for moderate to severe vision impairment in 101…
A third of babies and children in the UK diagnosed with childhood eye cancer have a squint as a symptom, according to new figures1.